SALT LAKE CITY -- Xenocor, Inc. today announced that the U.S. Food and Drug Administration (FDA) has cleared the new Xenocor Saberscope®, a single-use 5mm articulating laparoscope designed for high definition (HD) visualization during minimally invasive abdominal (belly) and thoracic (chest) surgical procedures.
The Saberscope® 5mm articulating disposable laparoscope is designed to deliver consistent, high-quality, full HD imaging while improving operating room workflow, reducing fogging, minimizing case delays, lowering hospital costs, and enhancing safety for patients and clinical staff.
Laparoscopic procedures typically rely on large, expensive image processing systems—often referred to as "towers"—and reusable surgical scopes that must be cleaned and reprocessed between patients. These towers can require hundreds of thousands of dollars in capital investment, while scope reprocessing is time-consuming, costly, and imperfect, introducing the risk of cross-contamination and procedural delays due to equipment availability.
The articulating Saberscope® features a single-use camera integrated into a 5mm rigid shaft with a 90-degree articulating tip, paired with a low-cost, compact reusable video processor that does not contact the patient. The processor connects via universal plug-and-play functionality and displays images on any standard HD monitor or through a hospital's existing tower system. After each procedure, clinicians dispose of the Saberscope to help reduce biohazard exposure and ensure that every case begins with a new, fully functional, non-contaminated endoscope.
The Saberscope® is FDA cleared for use in diagnostic and therapeutic endoscopic procedures within the thoracic and peritoneal cavities, including procedures involving the female reproductive organs.
Saberscope technology is also designed to reduce fogging during procedures, as demonstrated in initial clinical use and Xenocor test data. Reduced fogging can help maintain image clarity, limit procedural disruptions, shorten procedure time, and improve overall efficiency in the operating room.
Xenocor, Inc. is a privately held medical device company headquartered in Salt Lake City, Utah, focused on advancing surgical visualization through innovative, cost-effective technologies.
